Citation Impact
Citing Papers
Vaginal microbiome of reproductive-age women
2010 Standout
Combination bacteriolytic therapy for the treatment of experimental tumors
2001
The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
2016 StandoutScience
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3 + CD25 + CD4 + regulatory T cells
2005 StandoutNobel
Raised levels of plasma interleukin‐1β in major and postviral depression
2001
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
A Sex-Specific Role of Type VII Adenylyl Cyclase in Depression
2006
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Antipsychotic treatment may alter T-helper (TH) 2 arm cytokines
2005
Bioconjugated lanthanide luminescent helicates as multilabels for lab-on-a-chip detection of cancer biomarkers
2009
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo
2006
Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis
1999
Superoxide dismutase and cytokines in chronic patients with schizophrenia: association with psychopathology and response to antipsychotics
2009
Serum IL‐1β, sIL‐2R, IL‐6, IL‐8 and TNF‐α in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment
2001
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
Cytokines, “Depression Due to A General Medical Condition,” and Antidepressant Drugs
1999
Brain-Derived Tumor Necrosis Factor-α and Its Involvement in Noradrenergic Neuron Functioning Involved in the Mechanism of Action of an Antidepressant
2004
Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia
2008
Evidence for an immune response in major depression: A review and hypothesis
1995
Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients
2009
α1-antitrypsin deficiency
2005
Clostridia in cancer therapy
2003
Serum levels of soluble IL-2 receptor α, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration
1999
Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance
2002
Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model
2004
The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia
2008
Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review
2007
Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
2009 Standout
Toward an Anti-Inflammatory Strategy for Depression
2011
Herpes Viruses, Cytokines, and Altered Hemostasis in Vital Exhaustion
2003
In vivo immunomodulatory effects of clozapine in schizophrenia
1997
TNFα Signaling in Depression and Anxiety: Behavioral Consequences of Individual Receptor Targeting
2006
Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor
2002
Telomere shortening in T cells correlates with Alzheimer's disease status
2002
Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment
1997
Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression
2011
Imaging in the era of molecular oncology
2008 StandoutNature
Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia
1997
Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice
2009
The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms
2001
Cellular Senescence in Cancer and Aging
2007 Standout
Viral Chemokine Receptors and Chemokines in Human Cytomegalovirus Trafficking and Interaction with the Immune System
2002
Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics
2000
Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology
2002
Structure, Function and Clinical Significance of Transferrin Receptors
1999
Dynamics and associations of microbial community types across the human body
2014 StandoutNature
Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression
2010
Engineering the perfect (bacterial) cancer therapy
2010 Standout
Environmentally Controlled Invasion of Cancer Cells by Engineered Bacteria
2005
The role of immune dysfunction in the pathophysiology of autism
2011
The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines
2006
Estimated numbers and prevalence of PI*S and PI*Z alleles of α1-antitrypsin deficiency in European countries
2005
Exploiting tumour hypoxia in cancer treatment
2004 Standout
Neopterin and Macrophage Inflammatory Protein-1α in the Cerebrospinal Fluid of Schizophrenic Patients: No Evidence of Intrathecal Inflammation
2002
Functional Impairment of CD8+ T Cells by Regulatory T Cells during Persistent Retroviral Infection
2004 StandoutNobel
Cytokines sing the blues: inflammation and the pathogenesis of depression
2005 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Α Review on the Acute Phase Response in Major Depression
1993
Beneficial Antipsychotic Effects of Celecoxib Add-On Therapy Compared to Risperidone Alone in Schizophrenia
2002
Structure of the mammalian ribosomal pre-termination complex associated with eRF1•eRF3•GDPNP
2013 StandoutNobel
Neuroleptics normalize increased release of interleukin-1β and tumor necrosis factor-α from monocytes in schizophrenia
2001
Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of l-arabinose as inducer of bacterial gene expression in vivo
2007
Cytokine Production and Treatment Response in Major Depressive Disorder
2000
Cytokines, stress, and depressive illness
2002
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder
2003
A Membrane-proximal Basic Domain and Cysteine Cluster in the C-terminal Tail of CCR5 Constitute a Bipartite Motif Critical for Cell Surface Expression
2001 StandoutNobel
Plasma Cytokine Profiles in Subjects with High-Functioning Autism Spectrum Disorders
2011
The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs
2002
Seasonal Variation in Host Susceptibility and Cycles of Certain Infectious Diseases
2001
Cytokine profiles in schizophrenic patients treated with risperidone
2002
Cytokines as mediators of depression: What can we learn from animal studies?
2005
Possible association between ???G308A tumour necrosis factor-?? gene polymorphism and major depressive disorder in the Korean population
2003
Dysregulated diurnal cortisol pattern is associated with glucocorticoid resistance in women with major depressive disorder
2013
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
1999 StandoutNature
Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients
1996
Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics
2008
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
2013 StandoutNature
DADA2: High-resolution sample inference from Illumina amplicon data
2016 Standout
Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression
2010
Th1, Th2 and Th3 cytokine alteration in schizophrenia
2004
Cortisol and Cytokines in Chronic and Treatment-Resistant Patients with Schizophrenia: Association with Psychopathology and Response to Antipsychotics
2005
The Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review
2001
Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine
1995
A prospective evaluation of the directionality of the depression–inflammation relationship
2009
Major Depressive Disorder
2008 Standout
Major Depression and Activation of The Inflammatory Response System
1999
Live-cell assay to detect antigen-specific CD4+ T-cell responses by CD154 expression
2006
Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: Further evidence for an immune response
1994
Microbiota Modulate Behavioral and Physiological Abnormalities Associated with Neurodevelopmental Disorders
2013 Standout
Cytokines and schizophrenia: Microglia hypothesis of schizophrenia
2009
Meta-analyses of genetic studies on major depressive disorder
2007
The macrophage-T-lymphocyte theory of schizophrenia: Additional evidence
1995
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
2011 Standout
Interleukin-12 plasma levels in drug-naïve patients with a first episode of psychosis: Effects of antipsychotic drugs
2008
Reduced Cell Surface Expression of CCR5 in CCR5Δ32 Heterozygotes Is Mediated by Gene Dosage, Rather Than by Receptor Sequestration
2002 StandoutNobel
Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation
2011 StandoutNatureNobel
Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers
1995
The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
2010
An association between increased serum-soluble interleukin-2 receptors and a disturbance in muscle force in schizophrenic patients
1997
Exploring protein fitness landscapes by directed evolution
2009 StandoutNobel
The Human Plasma Proteome
2002 Standout
Bacterial therapies: completing the cancer treatment toolbox
2008
Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs
1996
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics
2000
The molecular neurobiology of depression
2008 StandoutNature
Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia
2003
The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies
2001 Standout
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Cloned Cytosine Deaminase Gene Expression ofBifidobacterium longumand Application to Enzyme/Pro-drug Therapy of Hypoxic Solid Tumors
2002
Time-resolved lanthanide luminescence for lab-on-a-chip detection of biomarkers on cancerous tissues
2009
Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK
2004
Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs
1997
Increased neuropeptide Y-like immunoreactivity in cerebrospinal fluid and plasma of human immunodeficiency virus-infected patients: relationship to HIV encephalopathy
1996
Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV
2003
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
COX-2 inhibition as a treatment approach in schizophrenia: Immunological considerations and clinical effects of celecoxib add-on therapy
2004
Human Immunodeficiency Virus Type 1 Controllers but Not Noncontrollers Maintain CD4 T Cells Coexpressing Three Cytokines
2007
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages
1999 StandoutNobel
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Lanthanide Luminescence for Biomedical Analyses and Imaging
2010 Standout
Investigation of serum cytokine levels and cytokine production in whole blood cultures of paranoid schizophrenic patients.
2001
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
2012 StandoutNobel
Elevated interleukin-6 in schizophrenia
1999
Effect of Risperidone on Serum Cytokines
2001
Mass spectrometry-based proteomics
2003 StandoutNature
Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease
1997 StandoutNobel
Vaginal Microbiome: Rethinking Health and Disease
2012
Soluble IL-6 receptors in the serum and cerebrospinal fluid of paranoid schizophrenic patients
1997
Serum Interleukin 1α and Interleukin 2 Levels in Patients with Schizophrenia
2002
Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients
2005
Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior
2011
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts
2008 Standout
Secretory production of biologically active rat interleukin-2 byClostridium acetobutylicumDSM792 as a tool for anti-tumor treatment
2005
Exaggerated neurobiological sensitivity to threat as a mechanism linking anxiety with increased risk for diseases of aging
2012
Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4 + T lymphocytes
2004
Host-Gut Microbiota Metabolic Interactions
2012 StandoutScience
Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1
1998
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
2010 StandoutNobel
Increased serum soluble CD8 or suppressor/cytotoxic antigen concentrations in depression: Suppressive effects of glucocorticoids
1996
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
CCR5 Levels and Expression Pattern Correlate with Infectability by Macrophage-tropic HIV-1, In Vitro
1997
Engineered bidirectional communication mediates a consensus in a microbial biofilm consortium
2007 StandoutNobel
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
The immune response in autism: a new frontier for autism research
2006
Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients
2001
Transmission Dynamics and Control of Severe Acute Respiratory Syndrome
2003 StandoutScience
G-protein-coupled Receptor (GPCR) Kinase Phosphorylation and β-Arrestin Recruitment Regulate the Constitutive Signaling Activity of the Human Cytomegalovirus US28 GPCR
2003 StandoutNobel
The microbial mimic poly IC induces durable and protective CD4+T cell immunity together with a dendritic cell targeted vaccine
2008 StandoutNobel
Chemical Glycoproteomics
2016 StandoutNobel
Mass Spectrometry and Protein Analysis
2006 StandoutScience
Works of E. Bosmans being referenced
Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis
2001
Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral blood B lymphocytes of patients with B chronic lymphocytic leukaemia
1999
Plasma soluble interleukin-2-receptor in depression: relationships to plasma neopterin and serum IL-2 concentrations and HPA-axis activity
1995
Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression
2001
Immune Disturbances during Major Depression: Upregulated Expression of Interleukin-2 Receptors
1990
Pathogenesis of abnormal vaginal bacterial flora
2000
Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer’s disease (DAT): Lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT
1998
Increased serum albumin, γ globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism
2002
Components of biological variation in plasma haptoglobin: relationships to plasma fibrinogen and immune variables, including interleukin-6 and its receptor
1995
Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining
1992
Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection
1998
Improvement ofClostridiumtumour targeting vectors evaluated in rat rhabdomyosarcomas
2001
Imbalance in Production of Cytokines by Bone Marrow Stromal Cells following Cytomegalovirus Infection
1996
Neonatal screening for alpha-1-antitrypsin deficiency
1988
Increased 24‐hour urinary cortisol excretion in patients with post‐traumatic stress disorder and patients with major depression, but not h patients with fibromyalgia
1998
Radio-responsive recA promoter significantly increases TNFα production in recombinant clostridia after 2 Gy irradiation
2001
Plasma-soluble interleukin-2 and transferrin receptor in schizoprenia and major depression
1995
The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6
1998
Depression‐related disturbances in mitogen‐induced lymphocyte responses and interleukin‐1β and soluble interleukin‐2 receptor production
1991
Seasonal variation in peripheral blood leukocyte subsets and in serum interleukin-6, and soluble interleukin-2 and-6 receptor concentrations in normal volunteers
1994
Components of biological variation in serum soluble transferrin receptor: relationships to serum iron, transferrin and ferritin concentrations, and immune and haematological variables
1997
A further exploration of the relationships between immune parameters and the HPA-axis activity in depressed patients
1991
Antiphospholipid, antinuclear, epstein-barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients
1991
Immune‐inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine
1994
THE EFFECTS OF ANTICOAGULATION AND PROCESSING ON ASSAYS OF IL-6, sIL-6R, sIL-2R AND SOLUBLE TRANSFERRIN RECEPTOR
1997
Suppressive effect of TRH and imipramine on human interferon-gamma and interleukin-10 production in vitro.
2001
Production of immunohistochemical reactivity of mouse anti-epithelial monoclonal antibodies raised against human breast cancer cells.
1990
Specific monoclonal antibodies reacting with human breast cancer cells.
1987
Alpha-1-proteinase inhibitor gene frequencies in Belgium.
1990
Effects of atypical antipsychotics on the inflammatory response system In schizophrenic patients resistant to treatment with haloperidol
1999
Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection
1999
Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects.
1993
Insertion or Deletion of the Cheo Box Modifies Radiation Inducibility of Clostridium Promoters
2001
Haptoglobin phenotypes and gene frequencies in unipolar major depression
1994
Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission.
2001